Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-13

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

The FDA approved a supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)